These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F, CLETRAT Investigators. Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210 [Abstract] [Full Text] [Related]
9. [Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins]. Vorob'eva NM, Panchenko EP, Ermolina OV, Balakhonova TV, Dobrovol'skiĭ AB, Titaeva EV, Khasanova ZB, Postnov AIu, Kirienko AI. Ter Arkh; 2011; 83(8):33-7. PubMed ID: 21961329 [Abstract] [Full Text] [Related]
10. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. De A, Roy P, Garg VK, Pandey NK. Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176 [Abstract] [Full Text] [Related]
11. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Misra UK, Kalita J, Chandra S, Kumar B, Bansal V. Eur J Neurol; 2012 Jul; 19(7):1030-6. PubMed ID: 22416902 [Abstract] [Full Text] [Related]